Global Continence Inc.

Global Continence is a pioneering healthcare company dedicated to transforming the landscape of Nocturnal Enuresis (NE) treatment. Our flagship product, Soluu®, is a revolutionary bedwetting device that harnesses the power of neuromodulation and remote signaling through non-invasive transcutaneous nerve stimulation (TENS) and a user-friendly app. NE affects millions of children globally, causing emotional distress and posing challenges for families. Current treatments often fall short, leading to discontinuation due to discomfort or ineffectiveness. Soluu® aims to revolutionize NE treatment with over 80% success within two months, as demonstrated in initial studies. Our innovative device not only promises improved treatment outcomes but also alleviates the emotional and financial burden on families dealing with NE. Global Continence is committed to making a positive impact on the lives of children suffering from NE, striving to reduce the emotional and financial burden on families worldwide. Join us in our mission to bring Soluu® to market and create lasting change for those affected by this challenging condition. #GlobalContinence #Soluu #HealthcareInnovation

• Employees 1
• Total Funding $835000